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Abstract
Aims/hypothesis Two recent genome-wide association studies
have identified several novel type 2 diabetes susceptibility
variantsinintron15oftheKCNQ1 gene. We aimed to evaluate
the effects of the variants in KCNQ1 on type 2 diabetes and
metabolic traits in the population of mainland China.
Methods Three candidate single nucleotide polymorphisms
were genotyped in 1,912 individuals with type 2 diabetes
and 2,041 normal controls using the ligase detection
reaction method.
Results We confirmed the association of KCNQ1 with type 2
diabetes in the population of mainland China. Allele
frequency ORs of the three single nucleotide polymorphisms
(SNPs) were: rs2237892 (OR 1.19, 95% CI 1.08–1.31,
p=3.0×10
−4); rs2237895 (OR 1.20, 95% CI 1.09–
1.32, p=1.9×10
−4); and rs2237897 (OR 1.24, 95% CI 1.13–
1.36, p=3 . 9×1 0
−5). We also found a significant difference in
the distribution of the global haplotypes between the
type 2 diabetes group and the normal control group
(p=2 . 6 × 1 0
−5). In addition, in the control group SNP
rs2237892 was marginally associated with increasing fasting
plasma glucose and SNPs rs2237892 and rs2237897 were
associated with HbA1c. Furthermore, for all three variants,
homozygous carriers of the diabetes-associated allele had
significantly decreased BMI and waist circumferences.
Conclusions/interpretation Our investigation confirmed the
effects of KCNQ1 variants on type 2 diabetes risk in the
Chinese population.
Keywords Association.KCNQ1.Mainland Chinese
population.Type2diabetes
Abbreviations
LD Linkage disequilibrium
PAR Population attributable risk
SNP Single nucleotide polymorphism
Introduction
Type 2 diabetes is a major health problem affecting more
than 200 million individuals worldwide. Its prevalence is
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Shanghai, People’s Republic of Chinaincreasing in many countries, especially in the developing
countries [1]. For example, the total number of people with
diabetes in China is estimated to increase from 20.8 million
in 2000 to 42.3 million by 2030. Type 2 diabetes is
characterised by the presence of insulin resistance and
pancreatic beta cell dysfunction, resulting from the interac-
tion of genetic and environmental factors.
So far a few genes, identified through linkage scans or
the candidate gene approach, have been confirmed as being
associated with type 2 diabetes e.g. PPARG, KCNJ11 and
TCF7L2 [2–4]. Recently, the use of genome-wide associ-
ation scans as an investigative tool has led to a qualitative
leap in identifying diabetes-related genes. Genome-wide
association studies conducted in large-scale case–control
samples by several independent European and American
research groups have identified several novel genes and loci
with modest effects on the risk of type 2 diabetes (OR
1.14–1.20), such as SLC30A8, HHEX, CDKAL1, CDKN2A,
CDKN2B, IGF2BP2 and FTO [5–10]. These studies have
been replicated and results confirmed in several other ethnic
groups [11–17].
The two most recent genome-wide association studies, in
the Japanese population, have identified the association of a
novel gene (KCNQ1) with the risk of type 2 diabetes; a
similar association was also detected in some Asian and
European populations in these studies [18, 19]. Recently,
Tan et al. also found variants in KCNQ1 to be associated
with type 2 diabetes, fasting glucose and beta cell function
in 3,734 individuals belonging to three ethnic groups living
in Singapore [20]. It is well known that there are significant
differences in the frequencies of some genetic variations
among different ethnic groups and geographic regions.
Therefore, we decided to investigate further the contribu-
tion of KCNQ1 to the aetiology of type 2 diabetes and to
determine whether variants of the KCNQ1 gene were
associated with the susceptibility to type 2 diabetes and
diabetes-related metabolic traits in the population of
mainland China. We also used haplotype analysis and the
best-fitting model test in our investigation.
Methods
Participants In this study, 3,953 Chinese Han participants
were recruited from Shanghai, China; these comprised
1,912 unrelated type 2 diabetic individuals (785 men, 1,127
women; age 63.9±9.5 years) and 2,041 control individuals
(635 men, 1,406 women; age 58.1±9.4 years). The study
population overlapped completely with that used in our
previous study [16]. Diabetic participants were defined in
accordance with WHO criteria. Controls with a fasting
plasma glucose concentration <6.1 mmol/l were enrolled
from the same geographical region. A standard informed
consent procedure was included in the protocol, and was
reviewed and approved by the Ethics Committee of the
Shanghai Institute for Biological Sciences. Participants
gave their consent after the nature of study had been fully
explained.
Blood samples were drawn for biochemical measure-
ments (fasting plasma glucose, HbA1c, total cholesterol,
triacylglycerol, HDL-cholesterol and LDL-cholesterol).
Height, weight, waist and hip circumferences, and blood
pressure were measured in all individuals. Data are showed
as medians (25–75% range) or means±SD (Table 1).
Single nucleotide polymorphism selection For the KCNQ1
gene, five single nucleotide polymorphisms (SNPs)
(rs2237892, rs2237895, rs2237897, rs2074196 and
rs2283228) were identified as having the most significant
association with type 2 diabetes based on previous studies
Characteristic Type 2 diabetes Controls
Number 1,912 2,041
Men/women (n/n) 785/1,127 635/1,406
Age (years) 63.9±9.5 58.1±9.4
BMI (kg/m
2) 25.3±3.48 24.5±3.24
Waist to hip ratio 0.89±0.06 0.86±0.06
Fasting blood glucose (mmol/l) 7.42 (6.08–9.49) 4.89 (4.51–5.25)
Triacylglycerol (mmol/l) 1.51 (1.07–2.19) 1.34 (0.94–1.91)
Total cholesterol (mmol/l) 4.40 (3.82–5.03) 4.44 (3.9–5.02)
HDL-cholesterol (mmol/l) 1.14 (0.96–1.35) 1.22 (1.03–1.46)
LDL-cholesterol (mmol/l) 2.7 (2.24–3.2) 2.74 (2.33–3.26)
Systolic blood pressure (mmHg) 140 (127–151) 130 (120–141)
Diastolic blood pressure (mmHg) 80 (76–90) 80 (74–89)
HbA1c (%) 7.11 (6.38–8.31) 5.80 (5.46–6.11)
Obesity (%) 20.7 14.1
Table 1 Clinical characteristics
of the study participants
Data are medians (25–75%
range) or means±SD
1316 Diabetologia (2009) 52:1315–1321[18–20]. After considering the linkage disequilibrium (LD)
structure based on HapMap Han Chinese and the pairwise
linkage disequilibrium D′ and r
2 values, we used rs2237892
to represent rs2074196 and rs2283228 (r
2= 0.73 and 0.95,
respectively) and thus selected three representative variants
(rs2237892, rs2237895 and rs2237897) to be genotyped in
our study.
Genotyping High molecular weight genomic DNA was
prepared from venous blood using the QuickGene 610L
Automatic DNA/RNA Extraction System (Fujifilm, Tokyo,
Japan). All the genotyping experiments were done using
ligase detection reactions [21]. All genotyping success rates
were above 98% and all mismatch rates were below 1% in
1641 duplicate samples.
Statistical analysis We used SHEsis [22] to perform the
Hardy–Weinberg equilibrium test, to compare the differ-
ences of allele, genotype and haplotype frequencies
between cases and controls and to calculate LD coefficients
(D′ and r
2) in the control group.
To establish the closest best-fit model for each SNP, we
carried out the logistic regression analysis by comparing
additive, dominant and recessive models with age, sex and
loge BMI as covariants, and the model that had the lowest
Akaike’s information criterion value was considered to be
the best-fitting model for the respective SNP. In the additive
model, homozygotes for the risk allele (1/1), heterozygotes
(1/0) and homozygotes for the non-risk allele (0/0) were
coded to an ordered categorical variable for the genotype
(2, 1 and 0, respectively). The dominant model was
defined as 1/1+1/0 vs 0/0 and the recessive model as 1/1 vs
1/0+0/0. The association of the SNPs with type 2 diabetes
was assessed by logistic regression after adjusting for sex,
age and loge BMI. The population attributable risk (PAR)
[23] was calculated as:
PAR ¼ 1  
1
nc
X
i2Case
1
ORi
where nc is the number if individuals in each case group and
ORi is equal to β×Y (the estimated OR of the ith individual
in each case group [β is the regression coefficient vector in
terms of Y, and Y is the term for the respective SNP in the
logistic regression model]). In addition, to analyse the
independent effect of each SNP in the KCNQ1 gene, we
carried out a conditional analysis by including the most
significant SNP in the region and the SNP being tested,
coded according to the most appropriate genetic model,
combined with age, sex and loge BMI as covariates, in a
logistic regression analysis.
For quantitative traits in relation to genotypes, a general
linear statistical method was used, applying additive,
dominant and recessive models while adjusting for the effect
of age and sex (BMI, waist and waist to hip ratio), or age, sex
and loge BMI (all other traits). The statistical analyses were
performed using the SPSS (SPSS, Chicago, IL, USA)
program. A p value <0.05 was considered significant.
Results
The allele and genotype distribution are summarised in
Table 2. All three variants genotyped were in Hardy–
Table 2 Association of candidate SNPs in KCNQ1 with type 2 diabetes in participants with type 2 diabetes and in controls
SNP Group Allele data Genotype distribution (%) Additive model
Allele Frequency
a
(%)
OR
(95% CI)
p value C/C C/R R/R OR
(95% CI)
p value
b
rs2237892
T
c,C
d
Case 69.6 1.19
(1.08–1.31)
3.0×10
−4 165 (8.8) 813 (43.2) 902 (48.0) 1.23
(1.11–1.36)
e
1.1×10
−4
Control 65.8 224 (11.2) 919 (46.0) 853 (42.7)
rs2237895
C
c,d,A
Case 34.6 1.20
(1.09–1.32)
1.9×10
−4 209 (11.1) 886 (47.0) 790 (41.9) 1.23
(1.11–1.37)
f
7.8×10
−5
Control 30.6 169 (8.5) 883 (44.3) 942 (47.2)
rs2237897
T
c,C
d
Case 68.4 1.24
(1.13–1.36)
3.9×10
−5 183 (9.7) 822 (43.8) 873 (46.5) 1.28
(1.16–1.41)
g
2.0×10
−6
Control 63.6 271 (13.6) 912 (45.7) 813 (40.7)
aRisk allele frequency
bAdjusted for age, sex and loge BMI
cMinor allele
dRisk allele
PAR (%)=
e23,
f12.6,
g27.3
C/C, homozygous for minor allele; C/R, heterozygous for minor allele; R/R, homozygous for common allele
Diabetologia (2009) 52:1315–1321 1317Weinberg equilibrium in both the case and control groups.
Allele frequency ORs of the three SNPs, rs2237892 (OR
1.19, 95% CI 1.08–1.31, p= 3.0×10
−4), rs2237895 (OR
1.20, 95% CI 1.09–1.32, p=1.9×10
−4) and rs2237897
(OR 1.24, 95% CI 1.13–1.36, p= 3.9×10
−5) were signif-
icantly associated with type 2 diabetes in our sample. The
risk alleles were in the same direction as in previous studies
[18, 19]. The best-fitting genetic model for all three was the
additive model (see Electronic supplementary material
[ESM] Table 1). Under the additive model with adjustment
for age, sex and loge BMI, significant association was
detected in all three polymorphisms (rs2237892, OR 1.23,
95% CI 1.11–1.36, p=1.1×10
−4, PAR=23.9%; rs2237895,
OR 1.23, 95% CI 1.11–1.37, p=7.8×10
−5, PAR=12.6%;
rs2237897, OR 1.28, 95% CI 1.16–1.41, p= 2.0×10
−6,
PAR=27.3%; Table 2).
The LD structure (rs2237892/rs2237895/rs2237897) is
shown in Fig. 1.L Dc o e f f i c i e n t s( D′ and r
2)a m o n gt h et h r e e
variants (see ESM Table 2) suggested that the degree of
linkage disequilibrium was relatively high. So haplotypes
were constructed with all three variants and the frequencies
of haplotypes were then analysed by excluding the rare
haplotypes (those below 2% frequency in cases or controls);
this revealed a significant difference in the distribution of the
global haplotypes between the type 2 diabetes group and the
normal controls (p=2 . 6 × 1 0
−5). The C-C-C haplotype
frequency was significantly higher (p= 2.1×10
−3)a n d
the T-A-T haplotype frequency was significantly lower
(p=4.0×10
−5) in the group with type 2 diabetes compared
with the control group (see ESM Table 3).
As treatment for diabetes may have affected metabolic
relationships, only non-diabetic individuals were included
in the metabolic traits analysis. We found all three variants
were associated with BMI and waist measurement, with the
homozygous carriers of diabetes-associated allele showing
the lowest value. Under the recessive model, rs2237892
and rs2237897 were associated with HbA1c levels and
rs2237892 also showed association with fasting plasma
glucose levels under the additive model (Table 3). Apart
from these associations, the variants were not associated
with any other measures in our study.
Discussion
We found the variants located at intron 15 of KCNQ1,
rs2237892, rs2237895 and rs2237897, to be associated with
type 2 diabetes. These results are consistent with previous
studies [18–20]. The variant rs2237897 showed the
strongest association with type 2 diabetes after testing for
independent effects, which was consistent with the study of
Tan et al. [20]. In addition, the conditional independent
effects test of rs2237892, rs2237895 and rs2237897
confirmed that they were in a linkage disequilibrium block,
as the effects of rs2237892 and rs2237895 on type 2
diabetes could be equally attributable to rs2237897 (see
ESM Table 4).
KCNQ1, which encompasses 404 kb, is located at
chromosome 11p15.5, not far from a candidate region at
11p13–p12 that two independent studies have linked to
type 2 diabetes [24, 25]. KCNQ1 encodes a pore-forming
subunit of the voltage-dependent K
+ ion channel, which is
expressed mainly in the heart and, to a lesser extent, in the
brain, adipose tissue and pancreas. The two most important
roles of potassium voltage-gated channel, KQT-like
(KCNQ1) channels are: (1) repolarisation of the cardiac
tissue following an action potential; and (2) water and salt
transport in epithelial tissues. Moreover, mutations in
KCNQ1 can lead to dysfunction of the channel and cause
the cardiac long QT syndrome LQTS1 that, in turn, may
lead to serious arrhythmias, ventricular fibrillation and
cardiac arrest. Kcnq1-knockout mice have been reported to
show cardiac dysfunctions such as prolonged QT interval,
hypochlorhydria, hypergastrinaemia, gastric hyperplasia
and vacuolation of the parietal cells [26, 27]. For type 2
diabetes, homozygous Kcnq1-null mice have been reported
not to show hyperglycaemia or glucose intolerance, and the
contribution of the KCNQ1-encoded protein to the molec-
ular pathogenesis of type 2 diabetes remains unclear [19].
We found that homozygous carriers of diabetes-associated
allele showed the lowest BMI in the control group, which
contradicted the theory that weight gain may increase the
risk of diabetes. This suggests that the KCNQ1 gene may
impact on the pathogenesis of diabetes through pathways
other than weight gain. The association of HbA1c levels and
Fig. 1 Linkage disequilibrium structure of the SNPs in KCNQ1.
Pairwise D′ values are colour coded: high D′ values are dark, low D′
values are light (values were generated by SHEsis software [22]). The
numbers shown at the top represent the degrees of the location of the
region on chromosome 11 (Chr11)
1318 Diabetologia (2009) 52:1315–1321fasting plasma glucose levels in our study, and the
association of higher fasting glucose levels and reduced
corrected insulin response at 120 min in the study of Tan et
al. [20], in conjunction with the lower homeostasis model
assessment for beta cell function or corrected insulin
response apparent for C-C homozygotes of rs2237892 in
the study of Yasuda et al. [18], may reflect a functional role
for this channel in beta cell function and the pathogenesis
of type 2 diabetes. Thus, further studies will be useful to
replicate these promising findings and to fully delineate the
role of KCNQ1.
In the present study, the distribution of haplotypes
constructed by rs2237892, rs2237895 and rs2237897
showed significant differences between cases and controls,
particularly the C-C-C haplotype and the T-A-T haplotype.
Thus, it can be seen that the three variants are in an LD
block. However, no variant in this region has been detected
to have a direct function, so we suggest that there may be
one or more other functional variants in this region of
KCNQ1. In a recent study, large gene deletions and
duplications in KCNQ1 were identified in people with long
QTsyndrome [28]. This suggests that copy-number variants
in KCNQ1 also play a role in associated complex diseases.
To clarify the role of KCNQ1 in susceptibility to type 2
diabetes, further research is needed into the SNPs and copy-
number variants.
In addition, compared with the controls in previous
studies (see ESM Table 5), the minor allele frequencies of
all three variants in our population from mainland China
were higher or lower than in other populations; for
example, the frequency of SNP rs2237897 in our Chinese
sample was close to that in the Singapore Chinese
Table 3 Effect of candidate SNP variant genotypes on clinical and biochemical variables in control individuals
SNP Risk
allele
Non-risk
allele
Phenotypic
characteristic
a
Genotypes p value
b
C/C C/R R/R Additive Dominant Recessive
rs2237892 C T BMI (kg/m
2) 24.3±3.13 24.7±3.30 24.7±3.42 0.039 0.483 0.020
Waist (cm) 82.9±9.08 83.2±8.79 84.9±16.3 0.043 0.019 0.223
Waist to hip ratio 0.86±0.06 0.86±0.07 0.86±0.07 0.635 0.492 0.844
Fasting plasma glucose
(mmol/l)
4.85±0.66 4.83±0.60 4.75±0.71 0.051 0.047 0.190
HbA1c (%) 5.81±0.55 5.75±0.53 5.77±0.69 0.064 0.781 0.012
Total cholesterol
(mmol/l)
4.52±0.90 4.48±0.88 4.53±0.80 0.517 0.583 0.221
Triacylglycerol
(mmol/l)
1.64±1.08 1.58±1.10 1.60±0.85 0.404 0.978 0.255
rs2237895 C A BMI (kg/m
2) 23.9±2.86 24.5±3.34 24.6±3.22 0.027 0.200 0.006
Waist (cm) 82.0±8.47 83.0±9.06 83.8±11.1 0.012 0.036 0.048
Waist to hip ratio 0.86±0.05 0.86±0.06 0.86±0.06 0.093 0.058 0.655
Fasting plasma glucose
(mmol/l)
4.82±0.69 4.85±0.62 4.81±0.65 0.188 0.081 0.913
HbA1c (%) 5.75±0.57 5.78±0.55 5.79±0.57 0.651 0.779 0.595
Total cholesterol (mmol/l) 4.42±0.84 4.51±0.88 4.51±0.88 0.748 0.811 0.245
Triacylglycerol
(mmol/l)
1.59±1.10 1.61±1.03 1.61±1.09 0.986 0.831 0.733
rs2237897 C T BMI (kg/m
2) 24.2±3.15 24.7±3.28 24.9±3.36 0.002 0.074 0.002
Waist (cm) 82.7±9.13 83.5±8.80 84.6±15.2 0.004 0.017 0.018
Waist to hip ratio 0.86±0.06 0.86±0.06 0.86±0.06 0.576 0.703 0.608
Fasting plasma glucose
(mmol/l)
4.82±0.66 4.85±0.61 4.77±0.68 0.562 0.155 0.854
HbA1c (%) 5.80±0.55 5.76±0.53 5.77±0.66 0.133 0.662 0.047
Total cholesterol (mmol/l) 4.52±0.90 4.47±0.87 4.56±0.83 0.630 0.368 0.193
Triacylglycerol
(mmol/l)
1.63±1.11 1.58±1.03 1.67±1.18 0.991 0.332 0.508
Data are means±SD
aMultiple linear regression was carried out after logarithmic transformation for data not in normal distribution
bAdjusted for age and sex (BMI, waist and waist to hip ratio), or age, sex and loge BMI (all other traits)
C/C, homozygous for risk allele; C/R, heterozygous for risk allele; R/R, homozygous for non-risk allele
Diabetologia (2009) 52:1315–1321 1319population, higher than that in the Japanese population and
completely different from the frequency in the Danish
population (63.8%, 65%, 61% and 96%, respectively) [18–
20]. These results confirmed the differences in frequencies
of some genetic variations among different ethnic groups
and different geographic regions. At the same time, these
differences also highlight the need to extend genome-wide
association scans and subsequent replication studies to
different populations.
In summary, we detected the association of KCNQ1 with
type 2 diabetes and some diabetes-related traits in the
population of mainland China. In addition, the haplotype
distribution was found to be significantly different between
cases and controls. These findings may be useful in further
research into the pathogenesis of type 2 diabetes, as well as
in advancing clinical practice and public health genomics.
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